Smith Nephew’s Post

Check out the latest report from IMIR Market Research Pvt. Ltd. on the 𝗘𝗹𝗲𝗰𝘁𝗿𝗼𝘀𝘂𝗿𝗴𝗶𝗰𝗮𝗹 𝗗𝗲𝘃𝗶𝗰𝗲𝘀 𝗠𝗮𝗿𝗸𝗲𝘁 Outlook and Geography Forecast till 2028 Don't miss out on this opportunity to stay informed about the latest trends in the industry. Electrosurgical Devices Market Size, Share & Trends Analysis Report By Product (Electrosurgical generator, Electrodes Smoke, evacuation system, Accessories), By Application (Cardiovascular surgery, Cosmetic surgery, Neurosurgery, General surgery, Gynaecology Urology, Orthopaedic surgery, Others), By End-use (Hospitals Ambulatory surgical, units Specialized clinics, Others), COVID-19 Impact Analysis, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2022 - 2028. 📚 𝐆𝐞𝐭 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐚𝐭 𝐝𝐢𝐬𝐜𝐨𝐮𝐧𝐭𝐞𝐝 𝐩𝐫𝐢𝐜𝐞:👇 https://lnkd.in/dGi7tzwB 📚𝐓𝐨𝐩 𝐌𝐨𝐫𝐞 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 𝐀𝐫𝐞::👇 Applied Medical  AtriCure, Inc. BKK B. Braun Melsungen AG Boston Scientific CONMED Corporation ELLMAN INTERNATIONAL (UK) LIMITED. Erbe Group  Ethicon, Inc.  Johnson & Johnson  KARL STORZ  KLS Martin Group Medtronic MEGADYNE MEDICAL PRODUCTS INC. Olympus Corporation PLASMA SURGICAL LIMITED Smith & Nephew Group Plc Stryker Symmetry Surgical. Utah Medical Products, Inc.

“What have we done”? Yet another concern to consider when making coverage decisions regarding GLP-1s. Using the lowest effective dose is foundational pharmaceutical care. If pharmaceutical companies won’t supply adjustable dosing for weight management versions then using diabetes version for weight management “off label” is a better option to consider.

The secret is out about Lacrifill, an #FDA-cleared #dryeyedisease therapy. So, who better to celebrate with than Darrell White, MD? Read Dr. White's thoughts about Lacrifill, which will be marketed by Nordic Pharma, in his latest Healio blog post. Find out why he's excited for this promising treatment and what benefits it may offer patients and #ophthalmologists. 🔗 below: #OcularSurgeryNews #Cornea #Eyedrops https://lnkd.in/ekBP-HS2

Cecelia Koetting, OD FAAO DipABO, (University of Colorado Anschutz Medical Campus) and Mile Brujic, OD, (PREMIER VISION GROUP) discuss how 2 new pharmaceutical treatments have the potential to change the paradigm for treating #DryEyeDisease. #MeibomianGlandDysfunction (MGD) has a number of causes, but only a single result: #OcularSurface dryness. In fact, most instances of dry eye disease (DED) (approximately 85%) have some evaporative component, often instigated by a dysfunction of the meibomian glands.1 Research shows that patients with MGD usually (approximately 85% of the time) have a preponderance of #Demodex mites, which leave cylindrical waste materials along the lash follicle, clogging the meibomian gland and, ultimately leading to Demodex blepharitis.2,3 Read more: https://brnw.ch/21wJdVg #MeibomianGland #MGD #OcularSurfaceDryness #DryEye #DryEyeSymptoms #EyeHealth #EyeCare #DED #Optometry #Optometrist

#Researchers, there is a pressing need to develop efficient, long-lasting drug delivery systems in ophthalmology, that reduce patient discomfort and increase compliance. With this call for proposals, we invite you to explore and progress drug delivery systems for intravitreal administration, with a particular focus on implantable/injectable formulation approaches and applicators. The goal is to create systems capable of maintaining therapeutic drug levels for at least three months, thereby reducing the frequency of drug administration. Discover more on #opnMe https://lnkd.in/ecNCRAEr #OpenScience #Boehringer

Vertex’s pain drug succeeds in late-stage studies, marking major breakthrough in search for new, non-opioid medicines >>> lqventures.com #strategy #competitiveintelligence #marketing #biotech #healthcare #productmarketing #pharma #pharmaceutical

𝗢𝗿𝘁𝗵𝗼𝗽𝗲𝗱𝗶𝗰 𝗱𝗲𝘃𝗶𝗰𝗲𝘀 𝗺𝗮𝗿𝗸𝗲𝘁 𝘁𝗼 𝗯𝗼𝗼𝗺, 𝗿𝗲𝗮𝗰𝗵𝗶𝗻𝗴 $𝟰𝟴.𝟭 𝗯𝗶𝗹𝗹𝗶𝗼𝗻 𝗯𝘆 𝟮𝟬𝟮𝟴 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞-https://lnkd.in/dGFWu6Pc The global orthopedic devices market in terms of revenue was estimated to be valued at $36.3 billion in 2022 and is poised to reach $48.1 billion by 2028, growing at a CAGR of 4.8% from 2022 to 2028 Stryker Johnson & Johnson Medtronic Smith Nephew Zimmer Biomet NuVasive B. Braun Group Enovis Acumed BSN medical CONMED Corporation Orthofix Arthrex Allegra Orthopaedics Limited DeRoyal Industries, Inc. MicroPort NIPPON SIGMAX TriMed Altis Biologics (Pty)Ltd. Isto Biologics Meril Life Sciences Mueller Sports Medicine, Inc. RCH Orthopaedics

Market Scope estimates that nearly 2,000 vitrectomy machines were sold globally in 2023. Looking forward, however, the percentage of United States retinal surgeons planning to purchase a new vitrectomy machine in the next 12 months continues to fall, down to only 2 percent in 2023 from a high of 6 percent in 2020. The main growth drivers for vitrectomy machines are typically technology upgrades, surgery center expansion, market penetration, and replacements. However, it’s possible a recent acquisition could prove to be a driver on its own. ZEISS Medical Technology’s December acquisition of DORC Dutch Ophthalmic Research Center (International) combines the strong reputation of the Eva vitrectomy machine with Zeiss’ status as a global market leader with extensive financial resources and established sales networks—all while filling the biggest void in Zeiss’ product line. Will this acquisition convince more surgeons it’s time to purchase a new machine? We will be closely monitoring this and much more in our Ophthalmic Market Trends—Quarterly US Retina Edition.      These concise, unbiased expert-reviewed, survey-based editions are published every quarter to drive innovation and uncover competitive intelligence. Coverage includes vitrectomy volume and locations, vitrectomy machine use and market share, reusable and disposable instruments, visualization agents, IVT injections by disease and product, DME treatments, corticosteroid use, and photocoagulation volume and usage. Please visit https://bit.ly/Q223OMT4 to learn more about these trends and subscribe, or email [email protected] to request a sample. #Vitrectomy #Machine #RetinalSurgery #PurchasePlans #MarketDrivers #Ophthalmology #Ophthalmic

The June edition of Market Scope’s Ophthalmic Market Perspectives newsletter has been published! This edition features curated coverage of Q1-2024 declines in ophthalmic procedures and company revenues; volume-based procurement possibly upending China's IOL market; surgeon and society response to MACs’ new proposed MIGS limits; upcoming innovations that are expected to rejuvenate the cataract surgical equipment market, and the #EBAA2024 meeting in Kansas City. This issue also covers Nordic Pharma launching Lacrifill canalicular gel for dry eye in the United States; Merck acquiring retinal drug developer EyeBio in a deal worth up to $3 billion; EU regulators approving Outlook Therapeutics, Inc.’s Lytenava for wet AMD; SIFI’s Acanthamoeba keratitis eye drop candidate gaining a positive CHMP opinion; BioTissue introducing its shelf-stable CAM360 AmnioGraft for dry eye and other disorders; Eversight partnering with LighTopTech Corp. to improve imaging of eye tissues; and researchers at the University of Missouri-Columbia finding that the COVID-19 virus can cross the blood-retinal barrier. This 36-page issue includes a total of 21 comprehensive news stories and 22 news briefs, highlights 11 clinical trial updates, and identifies three emerging companies pursuing ophthalmic indications—Eyebot, MediThinQ, and BIOPHTA. To subscribe or request a sample, please visit https://bit.ly/MSOMP or email [email protected]. #Ophthalmology #Ophthalmic #News #Market #IndustryNews #MeetingCoverage #EmergingCompanies #ClinicalTrials #Acquisitions

✔️4C Medical Technologies, Inc. announced the FDA granted breakthrough device designation for its AltaValve system. The company received designations for two therapeutic indications for the transcatheter mitral valve replacement device. 👏Saravana Kumar, CEO and President commented: “This advancement enables us the opportunity to bring this needed technology to our patients even sooner.” 🔗Read more: https://lnkd.in/dJjiTFhJ 📰 Follow Guided Solutions to receive the latest #MedTech news daily and subscribe to our weekly newsletter: https://lnkd.in/dYC56Usw #MedicalDevices #MedicalDevice #MedicalEquipment #Medicine #Surgeons #GuidedSolutions